Investment Rating - The report maintains a "Buy" rating for the company [10] Core Insights - The company has optimized its product structure, leading to price increases and sustained improvement in profitability, with strong shareholder return value highlighted [2][8] - In the fiscal year 2024, the company achieved a revenue of 80.65 billion, a year-on-year increase of 0.3%, and a net profit of 3.734 billion, reflecting a growth of 19.8% [4][8] Summary by Sections Revenue and Profitability - For the first half of 2024, the company reported a revenue of 39.45 billion, a slight decline of 0.2%, while the gross margin improved by 3.3 percentage points to 33.6%, resulting in a net profit of 1.849 billion, up 25.0% year-on-year [4][7] Product Performance - The instant noodle segment generated revenue of 28.414 billion, down 1.3% year-on-year, with high-priced noodles experiencing a significant decline of 6.3% for the year [5] - The beverage segment achieved revenue of 51.62 billion, a year-on-year increase of 1.3%, with tea drinks maintaining strong growth at 21.7 billion, up 8.2% [6] Margin Improvement - The company's sales net profit margin increased by 1.0 percentage points to 5.4%, with gross margin rising by 2.7 percentage points to 33.1% [7] - The report indicates that the trend of margin improvement is strengthening, although there is a slight increase in expenses [7] Shareholder Returns - The company maintained a high dividend payout ratio of 100%, resulting in a dividend yield of 5.6% based on the current market capitalization, showcasing strong shareholder return value [2][8]

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company is expected to achieve a revenue growth of 14.7% year-on-year in 2024, reaching 28.66 billion yuan, with a net profit growth of 36.9%, totaling 6.24 billion yuan, both exceeding expectations [1][10] - The company demonstrates strong competitive advantages, with orders growing faster than major brand clients, particularly benefiting from the performance of non-Nike clients [3][53] - The company is positioned to maintain its leading growth rate in the industry, with a target price adjustment to 75-82 HKD, reflecting a PE ratio of 16-17.5x for 2025 [3][54] Revenue and Profitability - Revenue is projected to grow by 14.8% in 2024, with net profit expected to increase by 36.9% [4][56] - The gross profit margin is anticipated to rise by 3.8 percentage points to 28.1% in 2024, with improvements in both the first and second halves of the year [1][10] - The company’s net cash position is 13.4 billion yuan, an increase of 2 billion yuan year-on-year [1] Customer and Product Performance - Performance varies by product category, with sportswear, casual wear, and underwear growing by 9.8%, 27.1%, and 34.6% respectively [2][27] - Customer performance shows significant growth for clients other than the second-largest client, with notable increases for clients A, C, and D [2][30] - The company is expected to benefit from the recovery of Nike, which has been under pressure, as it continues to outperform its competitors [45][51] Regional Performance - Revenue growth by region shows double-digit increases in China, with the US and Japan also seeing improved sales proportions [2][36] - The company’s revenue from China grew by 13.2%, while sales in Europe saw single-digit growth [36] Future Outlook - The company plans a 10% increase in production capacity for 2025, with stable pricing and gross margins [51] - The management indicates that if Nike recovers, there could be further upside potential for the company’s orders and performance [53][54]

Core Viewpoint - CICC maintains a "outperform" rating for Shenzhou International (02313) while lowering the target price by 14.5% to HKD 69.89, reflecting a decrease in overall industry valuation [1] Group 1: 2024 Performance - The company reported a 15% increase in revenue to RMB 28.7 billion and a 37% increase in net profit to RMB 6.2 billion, exceeding CICC's expectations due to higher-than-expected revenue growth and a one-time gain from asset sales of RMB 337 million [2] - The company declared a final dividend of HKD 1.28 per share, totaling HKD 2.53 per share for the year, with a payout ratio of 55.8% [2] - CICC expects a 17% revenue growth in 2H24 driven by a 20% year-on-year increase in order volume, maintaining high growth trends despite rising bases [2] Group 2: Sales Performance by Brand and Region - Revenue growth for major brands in 2H24 is projected as follows: Uniqlo +32%, Nike -2%, Adidas +48%, Puma +23%, indicating Shenzhou's increasing market share among key clients [2] - Revenue growth by region for 2024 is expected to be: China +13%, Europe +3%, Japan +32%, USA +19% [2] - A slight decline of approximately 3% in RMB unit price is anticipated in 2H24 due to product mix and raw material price decreases, although this is an improvement from a 7% decline in 1H24 [2] Group 3: Profitability and Cost Control - Gross margin is expected to increase by 3.8 percentage points year-on-year to 28.1% for 2024, with 2H24 gross margin at 27.4%, benefiting from improved capacity utilization [3] - A slight decrease in gross margin quarter-on-quarter is attributed to increased employee numbers and wages, but the company believes there is significant room for future margin improvement [3] - Despite a reduction in government subsidies and foreign exchange gains totaling RMB 145 million, net profit still achieved a 37% growth due to favorable factors including a gain from asset disposal [3] Group 4: Future Capacity and Order Growth - The company plans to increase its workforce by 10,000 to 102,700 employees in 2024, with new factory recruitment in Cambodia starting in March 2025 for about 6,000 positions [4] - Order volume is expected to maintain double-digit growth in 2025, despite pressures from major client Nike, supported by healthy growth from other clients [4] - As employee efficiency improves, the management anticipates a stable increase in gross margin for 2025 [4]

Core Viewpoint - The company reported a decline in revenue and net profit for 2024, primarily due to the divestment of its real estate business, but showed growth in core operations when excluding this impact [3][4]. Financial Performance - In 2024, the company achieved a revenue of 3.983 billion yuan, a year-on-year decrease of 13.0%, and a net profit attributable to shareholders of 244 million yuan, down 19.7%. However, excluding the impact of the real estate divestment, revenue remained flat, and net profit increased by 6.2% [3]. - The earnings per share (EPS) for 2024 was 0.24 yuan, with a proposed cash dividend of 0.06 yuan per share, resulting in a total payout ratio of 45.9% for the year [4]. Business Segmentation - The cosmetics segment saw a revenue increase of 2.5%, with the Yilian brand growing by 12% while the Ai'er Doctor brand experienced a slight decline [5]. - Revenue contributions from different segments in 2024 were as follows: cosmetics (62.2%), property management and others (15.4%), pharmaceuticals (12.9%), and raw materials and additives (8.6%) [5]. Sales Channels - Online sales dominated the cosmetics business, accounting for 87% of revenue, with a year-on-year growth of 1.8%, while offline sales represented 13% with a growth of 6.9% [5]. Profitability Metrics - The gross margin improved by 6.2 percentage points to 52.7% in 2024, with cosmetics, property management, pharmaceuticals, and raw materials having gross margins of 62.6%, 20%, 52.3%, and 35.9%, respectively [6]. - The operating cash flow for 2024 was 229 million yuan, a decrease of 51.8% year-on-year, primarily due to cash flow impacts from the real estate business divestment [7]. Expense Management - The total expense ratio increased by 3.7 percentage points to 44.8%, with specific increases in sales expenses (5.1 percentage points) and R&D expenses (0.8 percentage points) [7].